Urinary Retinol-Binding Protein: Relationship to Renal Function and Cardiovascular Risk Factors in Chronic Kidney

Maria Alice Muniz Domingos1, Silvia Regina Moreira2, Luz Gomez3

  • 1Nephrology Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.

Plos One
|September 23, 2016
PubMed

Insights

Urinary retinol-binding protein (RBP) is a significant biomarker for general chronic kidney disease (CKD) and its progression. This finding expands RBP

Area of Science:

  • Nephrology
  • Biomarker Discovery
  • Clinical Chemistry

Background:

  • Urinary retinol-binding protein (RBP) is a recognized biomarker for CKD in specific conditions like proximal tubular diseases, glomerulopathies, and post-transplantation.
  • Its role in general CKD progression and renal damage remains less understood.

Purpose of the Study:

  • To investigate the association between urinary RBP and renal function, as well as cardiovascular risk factors, in patients with stages 3 and 4 CKD.
  • To determine if urinary RBP can serve as a biomarker for CKD progression in a broader patient population.

Main Methods:

  • Analysis of baseline data from the Progredir Study, a CKD cohort in Sao Paulo, Brazil, with 454 participants.
  • Univariate and adjusted regression analyses to assess the relationship between urinary RBP, estimated glomerular filtration rate (eGFR), and cardiovascular risk factors.
  • Evaluation of RBP's ability to improve diagnostic accuracy for reduced eGFR.

Main Results:

  • Urinary RBP showed an inverse relationship with eGFR and several cardiovascular risk factors in univariate analysis.
  • After adjustments, eGFR, albuminuria, systolic blood pressure, anemia, acidosis, and left atrium diameter remained significantly associated with urinary RBP.
  • The inverse association between eGFR and urinary RBP persisted across all albuminuria strata and improved the diagnostic accuracy for eGFR < 35 ml/min/1.73m².

Conclusions:

  • Urinary RBP is significantly associated with renal function in general CKD, extending its utility beyond specific kidney conditions.
  • Urinary RBP holds potential as a predictive marker for CKD progression and warrants further investigation.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
538
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
287
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
952
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
88
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
574
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
876